Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

Completed · Phase 4

Conditions studied: Alcohol Related Disorders

In brief

The study objective was to determine whether liver injury develops in alcoholic patients who ingest therapeutic doses of APAP for three consecutive days. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4 g/day) or placebo for 3 consecutive days and remain in the facility an additional 2 days for monitoring. The primary measures were aminotransferase measures taken at baseline and Days 2-5. We hypothesized that there would be no difference in aminotransferase measures between the acetaminophen and placebo study groups.

Key facts

Study ID
NCT00402571
Run by
Denver Health and Hospital Authority
People needed
420
Starts
2002-01-01
Expected to finish
2004-07-01
Last updated by the study team
2009-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.